Collegium to Host Conference Call to Discuss Fourth Quarter and Full-Year 2021 Financial Results
Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced a conference call on February 24, 2022, at 4:30 p.m. ET to discuss its Q4 and full-year 2021 financial results. The call will be accessible via phone at (877) 407-8037 (U.S.) or (201) 689-8037 (International) and will also be available as a live audio webcast on their website. A replay will be posted approximately two hours after the event. Collegium is committed to advancing specialty pharmaceuticals aimed at improving patients' lives.
- The upcoming conference call indicates transparency and communication with investors regarding financial updates.
- Collegium is actively reporting its Q4 and full-year 2021 results, indicating performance assessment and accountability.
- None.
STOUGHTON, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that the Company will host a conference call and live audio webcast on Thursday, February 24, 2022, at 4:30 p.m. Eastern Time. The Company will discuss its fourth quarter and full-year 2021 financial results and provide a corporate update.
Conference Call Information
The Company will host a conference call and live audio webcast on Thursday, February 24, 2022, at 4:30 p.m. Eastern Time. To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the “Collegium Q4 2021 Earnings Call.” An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com. The webcast will be available for replay on the Company’s website approximately two hours after the event.
About Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical is building a leading, diversified specialty pharmaceutical company committed to improving the lives of people suffering from serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.
Contact:
Alex Dasalla
Head of Investor Relations and Corporate Communications
adasalla@collegiumpharma.com
FAQ
When is Collegium Pharmaceutical's Q4 2021 earnings call?
How can I access the Collegium Pharmaceutical earnings call?
What topics will be covered in Collegium Pharmaceutical's conference call?